TGFBI was found to be expressed in pancreatic cancer stem cells [52] and is thought to mediate immune tolerance through inhibition of cytotoxic T cell activation in pancreatic cancer. The gene discussed is TGFBI; the disease is familial pancreatic carcinoma.